论文部分内容阅读
目的探讨小儿支气管炎患者的临床治疗体会。方法选取我院2015年2月至2016年2月36例支气管炎患儿,随机分为治疗组与对照组两组,每组18例。对照组进行常规治疗,治疗组给予氨溴索和地塞米松氧气驱动雾化治疗。观察两组的临床疗效。结果治疗组显效7例,有效10例,无效1例,总有效率94.4%;对照组显效5例,有效8例,无效5例,总有效率为72.2%,两组治疗结果经统计学处理,治疗组与对照组比较差异有显著性(P<0.05);治疗组在缓解气喘,消除喘鸣音、湿啰音及住院时间方面与对照组有非常显着性差异(P<0.05)。结论氨溴索和地塞米松联合氧气驱动雾化吸入治疗小儿支气管炎疗效显著,起效快,不良反应小。
Objective To investigate the clinical treatment of children with bronchitis. Methods 36 children with bronchitis in our hospital from February 2015 to February 2016 were randomly divided into treatment group and control group, with 18 cases in each group. Control group for conventional treatment, the treatment group was given ambroxol and dexamethasone oxygen-driven atomization therapy. The clinical efficacy of the two groups was observed. Results In the treatment group, 7 cases were markedly effective, 10 cases were effective, 1 case was ineffective, and the total effective rate was 94.4%. In the control group, 5 cases were markedly effective, 8 cases were effective and 5 cases were ineffective. The total effective rate was 72.2% (P <0.05). There was a significant difference between the treatment group and the control group (P <0.05). The treatment group had significant difference (P <0.05) in alleviating asthma, eliminating wheeze, wet rales and hospital stay. Conclusion The combination of ambroxol and dexamethasone combined with oxygen-driven aerosol inhalation for the treatment of children with bronchitis has obvious curative effect, quick onset and small adverse reaction.